Chronic antepartum maternal hyperoxygenation in a case of severe fetal Ebstein's anomaly with circular shunt physiology
Related Experiment Video
Updated: Feb 22, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Alisa Arunamata1, David M Axelrod1, Katherine Bianco2
1Department of Pediatrics, Division of Pediatric Cardiology, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
Insights
Maternal oxygen therapy may help fetuses with Ebstein
Area of Science:
- Cardiology
- Fetal Medicine
- Neonatal Care
Background:
- Ebstein's anomaly of the tricuspid valve is associated with high perinatal mortality.
- Pulmonary valve regurgitation in fetuses with Ebstein's anomaly poses a particularly high risk.
- Circular shunt physiology and systemic steal are critical concerns in these cases.
Observation:
- A late-presenting case of Ebstein's anomaly with severe tricuspid regurgitation was observed.
- The fetus exhibited continuous pulmonary valve regurgitation and reversed ductal flow.
- Chronic antepartum maternal oxygen therapy was administered.
Findings:
- Maternal oxygen therapy led to fetal ductus arteriosus constriction.
- This intervention modulated fetal pulmonary vascular resistance.
- The strategy aimed to mitigate systemic steal in a complex cardiac defect.
Implications:
- Antepartum maternal oxygen therapy may be a novel strategy for managing fetal Ebstein's anomaly with pulmonary valve regurgitation.
- This approach could offer a new pathway to reduce perinatal mortality in high-risk fetal cardiac conditions.
- Further research is warranted to validate this therapeutic option in perinatal cardiology.
Abstract:
Perinatal mortality remains high among fetuses diagnosed with Ebstein's anomaly of the tricuspid valve. The subgroup of patients with pulmonary valve regurgitation is at particularly high risk. In the setting of pulmonary valve regurgitation, early constriction of the ductus arteriosus may be a novel perinatal management strategy to reduce systemic steal resulting from circular shunt physiology. We report the use of chronic antepartum maternal oxygen therapy for constriction of the fetal ductus arteriosus and modulation of fetal pulmonary vascular resistance in a late presentation of Ebstein's anomaly with severe tricuspid valve regurgitation, reversal of flow in the ductus arteriosus, and continuous pulmonary valve regurgitation.
Related Concept Videos
Fetal Circulation
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Oxygen Transport in the Blood
Acute Respiratory Failure-III
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

